Fundraising Fox
Nanochon
Washington, US · Founded 2021 · Delaware corporation · 15 employees on LinkedIn · 6 known investors
Find your way into Nanochon
Sign up to see every warm intro you have to Nanochon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanochon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanochon develops Chondrograft, a 3D-printed, off-the-shelf orthopedic implant that is press-fit into damaged knee cartilage to support the body's natural tissue healing. It targets "pre-replacement" patients with focal cartilage defects who need more than temporary relief but are not yet candidates for joint replacement.
Founders & leadership
Nanochon was founded in 2021 by Nathan Castro and Ben Holmes.
Board
Investors · 6
How we know: av.vc · Not right? Tell us
How we know: Genesis Innovation Group's portfolio page · Not right? Tell us
How we know: Wealthing VC Club's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9.6M disclosed across 3 rounds · 2021–2025
▶$3.6MraisedFeb 2026 · 39 investors · BiotechnologyRule 506(b)
- Benjamin HolmesExecutive Officer, Director
- Nick PachudaDirector
- Kurt JacobusDirector
- Robert CreedenDirector
- Sean ChurchillDirector
- Offering amount
- $4.2M
- Amount sold
- $3.6M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4MraisedMay 2024 · 34 investors · Other TechnologyRule 506(b)
- Benjamin HolmesExecutive Officer, Director
- Greg HornerDirector
- Robert CreedenDirector
- Nick PachudaDirector
- Kurt JacobusDirector
- Offering amount
- $6M
- Amount sold
- $4M
- Minimum investment
- $999
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2021 · 17 investors · Other TechnologyRule 506(b)
- Benjamin HolmesExecutive Officer, Director
- Nathan CastroExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Nanochon.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Nanochon do?
- Nanochon develops Chondrograft, a 3D-printed, off-the-shelf orthopedic implant that is press-fit into damaged knee cartilage to support the body's natural tissue healing. It targets "pre-replacement" patients with focal cartilage defects who need more than temporary relief but are not yet candidates for joint replacement.
- Who founded Nanochon?
- Nanochon was founded by Nathan Castro, Ben Holmes in 2021.
- Who are Nanochon's investors?
- Nanochon's investors include Alumni Ventures, Asimov Ventures, Genesis Innovation Group, Sand Hill Angels, Wealthing VC Club, TEDCO.
- How much funding has Nanochon raised?
- Nanochon has disclosed $9.6M raised across 3 rounds.
- Where is Nanochon headquartered?
- Nanochon is headquartered in Washington, US.